Abstract:

Hypertensive disorders commonly complicate pregnancies and they are one of the leading causes of maternal and perinatal morbidity and mortality globally. The objective of this study was to determine the prevalence, maternal-fetal complications, and predictors of feto-maternal complications among pregnant women with hypertensive diseases in a health facility in a low-resource setting in Enugu. This longitudinal study prospectively studied 167 mothers who had hypertension at any time in their pregnancy from June 2015 to May 2017. Data was collected at the admission and discharge of the patients using a structured proforma and analysed with Statistical Package for Social Sciences version 25. The result showed that the prevalence of hypertensive diseases in pregnancy was 4.42% with preeclampsia contributing 69.5% and gestational hypertension 19.2%. Hypertensive diseases in pregnancy were more common (38.9%) among the nulliparous women. The mode of delivery was mainly by caesarean section (65.3%). The mean gestational age at delivery was 36.53 ± 3.99 weeks and the mean birth weight was 2.6 ± 0.85 kg. Maternal and perinatal deaths were recorded in 2.4% and 25.2% of the patients, respectively. The predictors of fetal mortality were marital status (p =0.047, AOR =0.220, CI - 0.049 - 0.982) and the mode of delivery (P=0.000, AOR = 0.197, CI- 0.091- 0.425). In conclusion, the prevalence of hypertensive diseases in pregnancy was high in this study and associated with increased maternal and perinatal morbidity and mortality. The predictors of foetal mortality were both the marital status and the mode of delivery.

References:

[1]. American College of Obstetricians, 2013, Task Force on Hypertension in Pregnancy, Hypertension in pregnancy, Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy, Obstet Gynecol; 122: 1122–1131.

[2]. Sibai, B. M., 2003, Diagnosis and Management of Gestational Hypertension and Preeclampsia, Obstet Gynecol; 102: 181–192.

[3]. Peters, R. M., Flack, J. M., 2004, Hypertensive disorders of pregnancy, JOGNN - J Obstet Gynecol Neonatal Nurs; 33: 209–220.

[4]. Brown, M. A., Magee, L. A., Kenny, L. C., et al, 2018, Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice, Hypertension; 72: 24–43.

[5]. Khedagi, A. M, Bello, N. A, 2021, Hypertensive Disorders of Pregnancy, Cardiol Clin; 39: 77.

[6]. Leeman, L., Dresang, L. T., Fontaine P., 2016, Hypertensive Disorders of Pregnancy, Am Fam Physician; 93: 121–127.

[7]. Duley L., Henderson‐Smart, D. J., Chou, D., 2010, Magnesium sulphate versus phenytoin for eclampsia, Cochrane Database Syst Rev. Epub. DOI: 10.1002/14651858.CD000128.PUB2.

[8]. Turbeville, H. R., Sasser, J. M., 2020, Preeclampsia beyond pregnancy: Long-term consequences for mother and child, Am J Physiol - Ren Physiol; 318: F1315–F1326.

[9]. Villar, J., Say, l., Gulmezoglu, A. M., et al, 2003, Eclampsia and preeclampsia: a worldwide health problem for 2000 years, Preeclampsia; 189–207.

[10]. Ronsmans, C., Graham. W. J., 2006, Maternal mortality: who, when, where, and why, Lancet; 368: 1189–1200.

[11]. Kuklina, E. V., Ayala, C., Callaghan, W. M., 2009, Hypertensive disorders and severe obstetric morbidity in the United States, Obstet Gynecol; 113: 1299–1306.

[12]. Musa, J., Mohammed, C., Ocheke, A., et al, 2018, Incidence and risk factors for pre-eclampsia in Jos Nigeria, Afr Health Sci; 18: 584.

[13]. Ugwu, E. O., Dim, C. C., Okonkwo, C. D., et al, 2011, Maternal and perinatal outcome of severe pre-eclampsia in Enugu, Nigeria after introduction of Magnesium sulfate, Niger J Clin Pract; 14: 418–421.

[14]. Kooffreh, M., Ekott, M., Ekpoudom, D., 2014, The prevalence of pre-eclampsia among pregnant women in the University of Calabar Teaching Hospital, Calabar, Saudi J Heal Sci; 3: 133.

[15]. Oladokun, A., Okewole, A. I., Adewole, I. F., Babarinsa, I. A., 2000, Evaluation of cases of eclampsia in the University College Hospital, Ibadan over a 10 year period, West Afr J Med; 19: 192–194.

[16]. Pipkin, F. B., Rubin, P. C., 1994, Pre-eclampsia — the ‘disease of theories’, Br Med Bull; 50: 381–396.

[17]. Wang, A., Rana, S., Karumanchi, S. A., 2009, Preeclampsia: The role of angiogenic factors in its pathogenesis, Physiology; 24: 147–158.

[18]. Vandenbroucke, J. P., Von Elm E, Altman, D. G., et al, 2007, Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration, Epidemiology; 18: 805–835.

[19]. National Bureau of Statistics, 2020, Demographic Statistics Bulletin 2020, Natl Bur Stat; 1–26.

[20]. [Kale O. O., 1991, Methods of Epidemiological Studies. In: Bankole, M. A., (ed) Handbook of Research Methods In Medicine. Lagos: Nigerian Educational Research & Development Council (NERDC). 67 – 76.

[21]. Ebeigbe, P., Igberase, G., Aziken, M., 2007, Hypertensive disorders in pregnancy: experience with 442 recent consecutive cases in Benin city, Nigeria, Niger Med J; 48: 94–98.

[22]. Kirkwood, B. R., Sterne, J. A., 2003, Essential Medical statistics. Second. Malden, Massachusetts: Blackwell Science Ltd, 2003. DOI: 10.1002/sim.1961.

[23]. Mbachu, I., Udigwe, G., Okafor, C., et al., 2013, The pattern and obstetric outcome of hypertensive disorders of pregnancy in Nnewi, Nigeria, Niger J Med. 22(2):117-22.

[24]. Salako, B. L., Aimakhu, C. O., Odukogbe, A. A., Olayemi, O., Adedapo, K. S., 2004, A review of hypertensive disorders of pregnancy, Afr J Med Med Sci; 33: 99–103.

[25]. Singh, S., Ahmed, E., Egondu, S., et al, 2014, Hypertensive disorders in pregnancy among pregnant women in a Nigerian Teaching Hospital, Niger Med J; 55: 384.

[26]. Gemechu, K. S., Assefa, N., Mengistie, B., 2020, Prevalence of hypertensive disorders of pregnancy and pregnancy outcomes in Sub-Saharan Africa: A systematic review and meta-analysis, Women’s Health; 16. DOI: 10.1177/1745506520973105.

[27]. Hinkosa, L., Tamene, A., Gebeyehu, N., 2020, Risk factors associated with hypertensive disorders in pregnancy in Nekemte referral hospital, from July 2015 to June 2017, Ethiopia: Case-control study, BMC Pregnancy Childbirth; 20: 1–9.

[28]. Ugwu, A., Owie, E., Oluwole, A., et al, 2022, Maternal and perinatal outcomes of preeclampsia at a tertiary hospital in Lagos, Nigeria, Int J Med Heal Dev; 27: 197.

[29]. Ajah, L. O., Ozonu, N. C., Ezeonu, P. O., et al, 2016, The feto-maternal outcome of preeclampsia with severe features and eclampsia in Abakaliki, South-East Nigeria, J Clin Diagnostic Res; 10: QC18–QC21.

[30]. Wu, S. W., Zhang, W. Y., 2021, Effects of Modes and Timings of Delivery on Feto-Maternal Outcomes in Women with Severe Preeclampsia: A Multi-Center Survey in Mainland China, Int J Gen Med; 14: 9681–9687.

[31]. Amorim, M. M., Katz, L., Barros, A. S., et al, 2015, Maternal outcomes according to mode of delivery in women with severe preeclampsia: a cohort study, J Matern Neonatal Med; 28: 654–660.

[32]. Irene, K., Amubuomombe, P. P., Mogeni, R., et al, 2021, Maternal and perinatal outcomes in women with eclampsia by mode of delivery at Riley mother baby hospital: a longitudinal case-series study, BMC Pregnancy Childbirth; 21: 1–14.

[33]. Duley, L., Gülmezoglu, A. M., Henderson-Smart, D. J., Chou, D., 2013, Magnesium Sulphate and Other, Anticonvulsants for Women With Pre-Eclampsia, Cochrane Database Syst Rev. DOI: 10.1002/14651858.CD000025.

[34]. Ndaboine, E. M., Kihunrwa,A., Rumanyika, R., Im, H. B., Massinde, A. N., 2012, Maternal and perinatal outcomes among eclamptic patients admitted to Bugando Medical Centre, Mwanza, Tanzania, Afr J Reprod Heal; 16: 35–41.

[35]. Awoyesuku, P. A., John, D. H., John, D. H., Lebara, L. B., et al, 2020, Maternal and perinatal outcome in severe preeclampsia and eclampsia at the Rivers State university teaching hospital, Nigeria, Int J Reprod Contraception, Obstet Gynecol; 9: 4389.

[36]. Onwuhafua, P. I., Onwuhafua, A., Adze, J., et al, 2001, Eclampsia in Kaduna State of Nigeria--a proposal for a better outcome, Niger J Med; 10: 81–84.

[37]. Duley, L., Gülmezoglu, A. M., Chou, D., 2010, Magnesium sulphate versus lytic cocktail for eclampsia, Cochrane Database Syst Rev. DOI: 10.1002/14651858.cd002960.pub2.

[38]. Arntzen, A., Magnus, P., Bakketeig, L. S., et al, 1996, Marital Status as a Risk Factor for Fetal and Infant Mortality, Scand J Soc Med. 1996;24(1):36-42, http://dx.doi.org/101177/140349489602400106

[39]. Nwokoro, U. U., Dahiru, T., Olorukooba, A., Daam, C. K., et al., 2020, Determinants of perinatal mortality in public secondary health facilities , Abuja Municipal Area, PanAfrican Med J; 37: 1–12.

[40]. Balayla, J., Azoulay, L., Abenhaim, H. A., 2011, Maternal Marital Status and the Risk of Stillbirth and Infant Death: A Population-Based Cohort Study on 40 Million Births in the United States, Women’s Heal Issues; 21: 361–365.

[41]. Sharami, S. H., Kabodmehri, R., Sorouri, Z. R., et al, 2023, Neonatal Outcomes of Severe Preeclampsia in Neonates Under 34 Weeks of Gestation. J Kermanshah Univ Med Sci 274; 27, DOI: 10.5812/JKUMS-139136.

[42]. Elias, S., Wolde, Z., Tantu. T., et al, 2022, Determinants of early neonatal outcomes after emergency cesarean delivery at Hawassa University Comprehensive Specialised Hospital, Hawassa, Ethiopia, PLoS One; 17. DOI: 10.1371/JOURNAL.PONE.0263837.

[43]. Niyitegeka, .J, Nshimirimana, G., Silverstein, A., et al, 2017, Longer travel time to district hospital worsens neonatal outcomes: A retrospective cross-sectional study of the effect of delays in receiving emergency cesarean section in Rwanda, BMC Pregnancy Childbirth,17: 1–10.

[44]. Nyirahabimana, N., Ufashingabire, C. M., Lin, Y., et al, 2017, Maternal predictors of neonatal outcomes after emergency cesarean section: a retrospective study in three rural district hospitals in Rwanda, Matern Heal Neonatol Perinatol; 3: 1–9.

[45]. Coppage, K. H., Polzin, W. J., 2002, Severe preeclampsia and delivery outcomes: is immediate cesarean delivery beneficial? Am J Obstet Gynecol; 186: 921–923.

[46]. Abdullahi, Y. Y., Assefa, N., Roba, H. S., 2021, Magnitude and Determinants of Immediate Adverse Neonatal Outcomes Among Babies Born by Cesarean Section in Public Hospitals in Harari Region, Eastern Ethiopia, Research and Reports in Neonatology, DOI: 10.2147/RRN.S296534.